The Transgenic Animal Shared Facility provides efficient, cost-effective production of transgenic and genetically-engineered animal models for cancer investigators to accelerate genetic, biochemical, and cellular analyses of pathogenic mechanisms of cancer, as well as provide in vivo models for the assessment of human disease alleles and genetic avatars for personalized cancer therapies.

The Transgenic Animal Shared Facility services include:

  • Animal model development
  • Microinjection of nucleic acids
  • CRISPR synthesis and gene targeting
  • ES cell gene targeting (with & without screening)
  • ES cell microinjection
  • In vitro fertilization
  • Embryo and sperm cryopreservation
  • Assisted reproduction / re-derivations
  • Consulting and training

Leadership

Bob Kesterson headshot

Bob Kesterson, Ph.D. Director
This email address is being protected from spambots. You need JavaScript enabled to view it.

Management

Larry W. Johnson Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.